Diagnostic Power of Basal LH Compared to Peak LH After Stimulus Test in the Diagnosis of Central Precocious Puberty
1 other identifier
observational
213
1 country
1
Brief Summary
This is an observational, retrospective, single-center study focused on the diagnosis of Central Precocious Puberty in female patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
December 3, 2024
CompletedFirst Posted
Study publicly available on registry
December 6, 2024
CompletedDecember 6, 2024
October 1, 2024
2.6 years
December 3, 2024
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LH value
basal Lh value, and LH peak value after stimulus test with GnRH (mU/mL )
at baseline
Secondary Outcomes (5)
Uterine volume
at baseline
Longitudinal uterine diameter
at baseline
Presence of endometrial rhyme
at baseline
Ratio of peak LH/FSH values
at baseline
peak LH (mU/mL) value / FSH value ( mU/mL)
at baseline
Eligibility Criteria
Female patients undergoing GnRh testing for suspected diagnosis of Central Early Puberty between january 2017 and December 2020 at the Pediatrics Unit of IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola.
You may qualify if:
- Female patients with onset of signs of early pubertal development (onset of telarche) before the age of 8 years, who referred to the Pediatrics Unit of IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola between January 2017 and December 2020;
- Female patients undergoing GnRh testing for suspected diagnosis of Central Early Puberty between january 2017 and December 2020;
- Obtaining informed consent from parents/legal guardian of pediatric patients.
You may not qualify if:
- Patients with Peripheral precocious puberty.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Federico Baronio, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 3, 2024
First Posted
December 6, 2024
Study Start
May 25, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
December 6, 2024
Record last verified: 2024-10